Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases
出版年份 2021 全文链接
标题
Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases
作者
关键词
-
出版物
Frontiers in Immunology
Volume 12, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-12-01
DOI
10.3389/fimmu.2021.667354
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Bacterial and eukaryotic extracellular vesicles and non-alcoholic fatty liver disease: new players in the gut-liver axis?
- (2021) Alexandre Villard et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- A Mineralocorticoid Receptor Deficiency in Myeloid Cells Reduces Liver Steatosis by Impairing Activation of CD8+ T Cells in a Nonalcoholic Steatohepatitis Mouse Model
- (2021) Natalia Muñoz-Durango et al. Frontiers in Immunology
- Role of Metabolic Endotoxemia in Systemic Inflammation and Potential Interventions
- (2021) Shireen Mohammad et al. Frontiers in Immunology
- TREM2 sustains macrophage-hepatocyte metabolic coordination in nonalcoholic fatty liver disease and sepsis
- (2021) Jinchao Hou et al. JOURNAL OF CLINICAL INVESTIGATION
- Extracellular Vesicles as Inflammatory Drivers in NAFLD
- (2021) Akshatha N. Srinivas et al. Frontiers in Immunology
- Integrated Analysis of Key Genes and Pathways Involved in Nonalcoholic Steatohepatitis Improvement After Roux-en-Y Gastric Bypass Surgery
- (2021) Fu Chen et al. Frontiers in Endocrinology
- Liver macrophages and inflammation in physiology and physiopathology of non‐alcoholic fatty liver disease
- (2021) Ronan Thibaut et al. FEBS Journal
- Non-alcoholic fatty liver disease is associated with bacterial translocation and a higher inflammation response in psoriatic patients
- (2021) Isabel Belinchón-Romero et al. Scientific Reports
- Hepatic Dendritic Cells in the Development and Progression of Metabolic Steatohepatitis
- (2021) Nahum Méndez-Sánchez et al. Frontiers in Immunology
- Management of NAFLD patients with advanced fibrosis
- (2021) Douglas Maya‐Miles et al. LIVER INTERNATIONAL
- MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. GASTROENTEROLOGY
- Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH
- (2020) Javier Ampuero et al. JOURNAL OF HEPATOLOGY
- Pathogenesis of Chronic Plaque Psoriasis and Its Intersection With Cardio-Metabolic Comorbidities
- (2020) Paolo Gisondi et al. Frontiers in Pharmacology
- Multidimensional Impact of Mediterranean Diet on IBD Patients
- (2020) Fabio Chicco et al. INFLAMMATORY BOWEL DISEASES
- Lytic cell death in metabolic liver disease
- (2020) Jérémie Gautheron et al. JOURNAL OF HEPATOLOGY
- Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically-characterised cohort
- (2020) Quentin M. Anstee et al. JOURNAL OF HEPATOLOGY
- The cellular pathways of liver fibrosis in non-alcoholic steatohepatitis
- (2020) Nahum Méndez-Sánchez et al. Annals of Translational Medicine
- The Physiology, Pathology, and Potential Therapeutic Applications of the TREM2 Signaling Pathway
- (2020) Aleksandra Deczkowska et al. CELL
- Hsd17b13 Deficiency Does not Protect Mice From Obesogenic Diet Injury
- (2020) Yanling Ma et al. HEPATOLOGY
- Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
- (2020) Austin Lin et al. INFLAMMATORY BOWEL DISEASES
- Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis
- (2020) Susanne Gaul et al. JOURNAL OF HEPATOLOGY
- Bacterial antigen translocation and age as BMI‐independent contributing factors on systemic inflammation in NAFLD patients
- (2020) Isabel Gómez‐Hurtado et al. LIVER INTERNATIONAL
- Genetic variant rs72613567 of HSD17B13 gene reduces alcohol‐related liver disease risk in Chinese Han population
- (2020) Haizhen Chen et al. LIVER INTERNATIONAL
- TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms
- (2020) Aitor Esparza-Baquer et al. GUT
- Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort
- (2020) Tracey G Simon et al. GUT
- The role of neutrophils in innate immunity-driven nonalcoholic steatohepatitis: lessons learned and future promise
- (2020) Lihong Wu et al. Hepatology International
- Osteopontin Expression Identifies a Subset of Recruited Macrophages Distinct from Kupffer Cells in the Fatty Liver
- (2020) Anneleen Remmerie et al. IMMUNITY
- Role of fructose in NASH defined
- (2020) Shimona Starling Nature Reviews Endocrinology
- Accuracy of cytokeratin 18 (M30 and M65) in detecting non-alcoholic steatohepatitis and fibrosis: A systematic review and meta-analysis
- (2020) Jenny Lee et al. PLoS One
- Current perspectives on the pathophysiology of metabolic associated fatty liver disease: are macrophages a viable target for therapy?
- (2020) Mikkel Breinholt Kjær et al. Expert Review of Gastroenterology & Hepatology
- Kupffer Cells Sense Free Fatty Acids and Regulate Hepatic Lipid Metabolism in High-Fat Diet and Inflammation
- (2020) Kira L. Diehl et al. Cells
- Immunological mechanisms and therapeutic targets of fatty liver diseases
- (2020) Hua Wang et al. Cellular & Molecular Immunology
- The health impact of MAFLD, a novel disease cluster of NAFLD, is amplified by the integrated effect of fatty liver disease related genetic variants
- (2020) Zhenqiu Liu et al. Clinical Gastroenterology and Hepatology
- RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease
- (2020) Marta B Afonso et al. GUT
- Cell Death in Liver Diseases: A Review
- (2020) Layla Shojaie et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Chronic Inflammation in Non-Alcoholic Steatohepatitis: Molecular Mechanisms and Therapeutic Strategies
- (2020) Carmelo Luci et al. Frontiers in Endocrinology
- Evidence for liver and peripheral immune cells secreting tumor-suppressive extracellular vesicles in melanoma patients
- (2020) Jung-Hyun Lee et al. EBioMedicine
- Function of TREM1 and TREM2 in Liver-Related Diseases
- (2020) Huifang Sun et al. Cells
- Comparative Analysis of the Transcriptome, Proteome, and miRNA Profile of Kupffer Cells and Monocytes
- (2020) Andrey Elchaninov et al. Biomedicines
- Maternal High-Fat Diet Leads to Non-alcoholic Fatty Liver Disease Through Upregulating Hepatic SCD1 Expression in Neonate Rats
- (2020) Baige Cao et al. Frontiers in Nutrition
- Inflammation initiates a vicious cycle between obesity and nonalcoholic fatty liver disease
- (2020) Yunfei Luo et al. Immunity Inflammation and Disease
- Identification of a Metabolic, Transcriptomic, and Molecular Signature of Patatin‐Like Phospholipase Domain Containing 3–Mediated Acceleration of Steatohepatitis
- (2020) Bubu A. Banini et al. HEPATOLOGY
- A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanisms
- (2019) Rasha El Sharkawy et al. Scientific Reports
- Adipose tissue-derived stem cells prevent fibrosis in murine steatohepatitis by suppressing IL-17-mediated inflammation
- (2019) Masatoshi Yamato et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Systematic Review With Meta-analysis: Epidemiology of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease
- (2019) Zi-Yuan Zou et al. INFLAMMATORY BOWEL DISEASES
- Role of Myeloid-Epithelial-Reproductive Tyrosine Kinase and Macrophage Polarization in the Progression of Atherosclerotic Lesions Associated With Nonalcoholic Fatty Liver Disease
- (2019) Mirella Pastore et al. Frontiers in Pharmacology
- Nonalcoholic fatty liver disease puts patients with psoriasis at greater cardiovascular risk
- (2019) David Romero-Pérez et al. AUSTRALASIAN JOURNAL OF DERMATOLOGY
- High prevalence of non‐alcoholic fatty liver disease among hidradenitis suppurativa patients independent of classic metabolic risk factors
- (2019) C. Durán‐Vian et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Resolving the fibrotic niche of human liver cirrhosis at single-cell level
- (2019) P. Ramachandran et al. NATURE
- Adaptive immunity: an emerging player in the progression of NAFLD
- (2019) Salvatore Sutti et al. Nature Reviews Gastroenterology & Hepatology
- Macrophage MerTK Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis
- (2019) Bishuang Cai et al. Cell Metabolism
- Tolerogenic properties of liver macrophages in non‐alcoholic steatohepatitis
- (2019) Lorenzo A. Orci et al. LIVER INTERNATIONAL
- Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis
- (2018) Dirk J. van der Windt et al. HEPATOLOGY
- IRGM Gene Variants Modify the Relationship Between Visceral Adipose Tissue and NAFLD in Patients With Crohn’s Disease
- (2018) Tracey G Simon et al. INFLAMMATORY BOWEL DISEASES
- Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease
- (2018) Alessandro Sartini et al. Cell Death & Disease
- Association of Psoriasis With Comorbidity Development in Children With Psoriasis
- (2018) Megha M. Tollefson et al. JAMA Dermatology
- DAP12/TREM2 Expression by Mouse and Human Liver DC: Functional Implications and Regulation of Liver Ischemia-Reperfusion Injury
- (2018) Toshimasa Nakao et al. HEPATOLOGY
- Splice variant rs72613567 prevents worst histologic outcomes in patients with nonalcoholic fatty liver disease
- (2018) Carlos J. Pirola et al. JOURNAL OF LIPID RESEARCH
- Interferon lambda 4 rs368234815 TT>δG variant is associated with liver damage in patients with nonalcoholic fatty liver disease
- (2017) Salvatore Petta et al. HEPATOLOGY
- MERTK rs4374383 variant predicts incident nonalcoholic fatty liver disease and diabetes: role of mononuclear cell activation and adipokine response to dietary fat
- (2017) Giovanni Musso et al. HUMAN MOLECULAR GENETICS
- CD44 is a key player in non-alcoholic steatohepatitis
- (2017) Stéphanie Patouraux et al. JOURNAL OF HEPATOLOGY
- Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD
- (2017) Hannes Hagström et al. JOURNAL OF HEPATOLOGY
- Effects of lifestyle intervention on soluble CD163, a macrophage activation marker, in patients with non-alcoholic fatty liver disease
- (2017) Sidsel Rødgaard-Hansen et al. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- Increased parenchymal damage and steatohepatitis in Caucasian non-alcoholic fatty liver disease patients with common IL1B and IL6 polymorphisms
- (2016) J. E. Nelson et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver disease
- (2016) Konstantin Kazankov et al. LIVER INTERNATIONAL
- Neutrophils Play a Crucial Role in the Early Stage of Nonalcoholic Steatohepatitis via Neutrophil Elastase in Mice
- (2015) Shufei Zang et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- The receptor CD44 is associated with systemic insulin resistance and proinflammatory macrophages in human adipose tissue
- (2015) Li Fen Liu et al. DIABETOLOGIA
- Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
- (2015) Eduardo Vilar-Gomez et al. GASTROENTEROLOGY
- Macrophage activation marker soluble CD163 and non-alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery
- (2015) Konstantin Kazankov et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- CD Nomenclature 2015: Human Leukocyte Differentiation Antigen Workshops as a Driving Force in Immunology: Table I.
- (2015) Pablo Engel et al. JOURNAL OF IMMUNOLOGY
- Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease
- (2015) Mohammed Eslam et al. Nature Communications
- Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease
- (2014) Pierre Bedossa et al. HEPATOLOGY
- NLRP3 inflammasome activation is required for fibrosis development in NAFLD
- (2014) Alexander Wree et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Is serum Interleukin-17 associated with early atherosclerosis in obese patients?
- (2014) Giovanni Tarantino et al. Journal of Translational Medicine
- IL-17 signaling accelerates the progression of nonalcoholic fatty liver disease in mice
- (2013) Isaac T.W. Harley et al. HEPATOLOGY
- Dendritic cells in liver injury and fibrosis: Shortcomings and promises
- (2013) Veronika Lukacs-Kornek et al. JOURNAL OF HEPATOLOGY
- CD44 Plays a Critical Role in Regulating Diet-Induced Adipose Inflammation, Hepatic Steatosis, and Insulin Resistance
- (2013) Hong Soon Kang et al. PLoS One
- Soluble CD163
- (2011) Holger J. Møller SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice
- (2010) Kouichi Miura et al. GASTROENTEROLOGY
- Depletion of Liver Kupffer Cells Prevents the Development of Diet-Induced Hepatic Steatosis and Insulin Resistance
- (2009) W. Huang et al. DIABETES
- Increased activity of interleukin-23/interleukin-17 proinflammatory axis in obese women
- (2008) M Sumarac-Dumanovic et al. INTERNATIONAL JOURNAL OF OBESITY
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
- (2008) Stefano Romeo et al. NATURE GENETICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now